Fjarde Ap Fonden Royalty Pharma PLC Transaction History

Fjarde Ap Fonden

$9.89 Billion
Q4 2024

A detailed history of Fjarde Ap Fonden transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fjarde Ap Fonden holds 126,550 shares of RPRX stock, worth $3.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

126,550

Previous 85,250 48.45%

Holding current value

$3.96 Million

Previous $2.41 Million 33.83%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$24.28 - $28.39 $1 Million - $1.17 Million	41,300 Added 48.45%	126,550 $3.23 Million
Q3 2024 Nov 08, 2024	SELL	$25.63 - $29.27 $238,359 - $272,211	-9,300 Reduced 9.84%	85,250 $2.41 Million
Q1 2024 Apr 25, 2024	SELL	$27.46 - $31.33 $529,978 - $604,669	-19,300 Reduced 16.95%	94,550 $2.87 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $838,720 - $935,040	32,000 Added 39.1%	113,850 $3.2 Million
Q3 2023 Oct 23, 2023	SELL	$26.26 - $31.38 $186,446 - $222,798	-7,100 Reduced 7.98%	81,850 $2.22 Million
Q2 2023 Aug 02, 2023	SELL	$29.6 - $36.56 $1.29 Million - $1.59 Million	-43,600 Reduced 32.89%	88,950 $2.73 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $961,799 - $1.16 Million	29,350 Added 28.44%	132,550 $4.78 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $238,937 - $268,644	-6,100 Reduced 5.58%	103,200 $4.08 Million
Q2 2022 Aug 11, 2022	SELL	$37.53 - $44.22 $1.22 Million - $1.44 Million	-32,600 Reduced 22.97%	109,300 $4.6 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $801,644 - $908,216	21,400 Added 17.76%	141,900 $5.53 Million
Q4 2021 Feb 15, 2022	BUY	$35.17 - $42.48 $2.03 Million - $2.45 Million	57,600 Added 91.57%	120,500 $4.8 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $25,298 - $29,568	700 Added 1.13%	62,900 $2.27 Million
Q2 2021 Aug 12, 2021	SELL	$39.85 - $46.63 $179,325 - $209,835	-4,500 Reduced 6.75%	62,200 $2.55 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $1.03 Million - $1.28 Million	24,300 Added 57.31%	66,700 $2.91 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $1.53 Million - $2.12 Million	42,400 New	42,400 $2.12 Million

Others Institutions Holding RPRX

# of Institutions

412

Shares Held

281M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $13.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account